nrf2 glutathione peroxidase schizophrenia Recent Advances in Understanding Agonism and Its Potential Clinical Application to Metabolic and Inflammatory Diseases New insights into crosstalk between
Description
elegans from P
Trials conducted between 2001 and 2007 demonstrated statistically significant reductions in body fat, although the larger Phase IIb OPTIONS trial did not replicate these findings at sufficient magnitude for regulatory approval, and formal development was discontinued in 2007
PMID: 27795561
Several antitumor drugs, including oxaliplatin, cause damage to neuronal and nonneuronal mitochondria, thus leading to oxidative stress mediated by redox-sensitive TRPA1 channels
Xiong ZE, Dong WG, Wang BY, Tong QY, Li ZY
